ATS: Pirfenidone Slows IPF Lung Declines

Courtesy MedPage Today Allergy & Immunology  Tue, 05/20/2008 - 14:05

TORONTO -- An investigational anti-fibrotic agent is showing promise in the treatment of idiopathic pulmonary fibrosis (IPF), a researcher said here.


 

More related items

House Screening Confers Prenatal Lead Protection...
DALLAS (MedPage Today) -- Screening older houses that may have lead contamination is an effective way of reducing the exposure of at-risk children, a researcher said here.

ASH: Presurgery Transfusion Cuts Risk in Sickle Cell...
SAN DIEGO (MedPage Today) -- Sickle cell patients who need surgery should be offered a transfusion first, a researcher said here.

AASLD: New PI Effective, Safe in HCV Trial (CME/CE)
SAN FRANCISCO (MedPage Today) -- An investigational hepatitis C drug was safe and effective in a small randomized trial, a researcher said here.

Country Save HE Laundry Detergent, Powder, 160-Load,...

Yogi Tea Calm, Bedtime, Tea Bags, 16-Count Boxes...


 

Post new comment

The content of this field is kept private and will not be shown publicly.
health-fitness.marc8.com